Introduction
============

Cardiovascular (CV) disease, and in particular coronary artery disease (CAD), is a multifactor syndrome that represents the leading cause of death, accounting for over 15 million deaths worldwide each year.[@b1-tcrm-7-059],[@b2-tcrm-7-059] In addition to the well-known nonmodifiable risk factors for CV disease, such as sex (ie, male gender), age, and genetic predisposition[@b3-tcrm-7-059] there are a number of modifiable factors which could -- to some extent -- be prevented.[@b4-tcrm-7-059]

The major modifiable risk factors for CV disease are smoking, hypertension, diabetes, and hypercholesterolemia.[@b1-tcrm-7-059],[@b2-tcrm-7-059]

The impact of these factors in the development and worsening of CAD has been unequivocally demonstrated by international controlled epidemiologic studies and large pharmaceutical trials.[@b1-tcrm-7-059],[@b2-tcrm-7-059] Over the years, research has identified over 200 additional risk factors (eg, bio-humoral, lifestyle behaviors, and psychosocial factors) associated with CAD,[@b5-tcrm-7-059]--[@b13-tcrm-7-059] but what has not yet been extensively investigated is the true clinical relevance for the majority of them, especially compared with that of conventional factors.

A number of algorithms and scoring systems have been developed to calculate absolute risk, ranging from simple-to-use scores to complicated computer-based algorithms, all of which are based, however, on just a few risk parameters. A fundamental problem for all risk algorithms is that they make significantly different assumptions about the nature of mathematical relationships that exist between the individual variables.[@b14-tcrm-7-059],[@b15-tcrm-7-059]

Physicians often underestimate their patient's CV risk.[@b16-tcrm-7-059] Only 13% of primary care physicians are said to use a risk chart to assess patient's risk. In another study it was not possible to calculate a CV risk using guidelines for 43% of patients because of deficiency of information.[@b17-tcrm-7-059] The likely explanations are that very often the risk computation is performed after and out of the medical consultation, and the recording is paper-based and not computerized. Moreover, recent studies have shown that in general practice it has not been possible to calculate CV risk in 50% of patients because of low levels of information recordings.[@b3-tcrm-7-059] Even for well-known CV risk factors (eg, blood pressure), less than 25% of patients with hypertension have adequate blood pressure control due to lack of adherence to international guidelines,[@b14-tcrm-7-059] and less than 10% have both blood pressure and cholesterol controlled.[@b15-tcrm-7-059],[@b17-tcrm-7-059]

The aim of the paper is to present a new computer-based program, developed by the National Council Research Institute of Clinical Physiology of Pisa, with the following goals: 1) to calculate easily and compare the absolute risk using the two major risk score algorithms that exist today and by using the Italian Progetto Cuore risk chart; 2) to design a web-based computerized tool for long-term and prospective collection of structured data utilized for developing a reliable algorithm able to identify correctly individuals at risk; 3) to support the doctor in the decision making process for patients at risk according to the recent international guidelines to improve the care of patients with CAD.

Materials and methods
=====================

General aspects of the computer-based program
---------------------------------------------

We developed the software VIRC (Valutazione Integrata del Rischio Cardiovascolare, ie, Integrated Evaluation of Cardiovascular Risk) for use free of charge, without commercial license, by the medical community anywhere in the world. New users can register with their personal identification, medical institution, and title by visiting the web server homepage (<https://virc.ifc.cnr.it>). A personal account is generated and communicated via email.

The computer-based program enables physicians to use their computer during patient appointments to collect in a systematic way the data on the patient's clinical status.

Development of the project included the following steps: 1) definition of dataset; 2) execution of a pilot study on a limited series of patients (n = 294); 3) territorial extension of the pilot study with involvement of 20 practitioners to obtain a relatively large sample of patients enrolled (n = 3000 in current year); 4) adjustment of the model data, if necessary, on the basis of indications raised by pilot studies; 5) extension of the program with enrollment of at least 10,000 patients, a number considered appropriate for preliminary epidemiological studies, in 18 months. The first two steps have now been completed and step 3 is now in progress in the Tuscan territory. Next year a final report is expected on the Tuscany study, and if the results are positive, an international trial will be set up.

Dataset
-------

The medical dataset was created by a research group of specialists (cardiologists, internal medicine specialists, endocrinologists, and others) on the basis of the importance of each CVD factor as stated in international medical literature. Two international guidelines were selected: 1) Pocket guide to prevention of coronary heart disease prepared by the International Heart Task Force.[@b14-tcrm-7-059] This is a comprehensive guideline based on recommendations by the International Arteriosclerosis Society, The American Heart Association, The American College of Cardiology, The US National Heart Lung and Blood Institute, the Joint European Cardiovascular Societies, The World Heart Organization, and on the contents of the third report by the Adult Treatment Panel of the National Cholesterol Education Program; and 2) Specific and updated evidence-based guidelines for CV disease prevention in women.[@b18-tcrm-7-059]

Patient records are stored on a central database server together with the application software accessible through a firewalled web server. Access to patient data is restricted to the physician and, exceptionally, to operators in anonymous epidemiological studies; in all other cases access is subordinated to explicit patient consent.

The physician, as a client, links to the database server using a secure internet protocol by means of a common computer, through a personal account for login and a common web browser as software interface, regardless of operating system, memory amount, and computer performance. All patient data sent on the Internet are coded using a secure protocol which safeguards the confidentiality of data transmission to the server. Client--server network layout to enter the software and patient's data is schematically depicted in [Figure 1](#f1-tcrm-7-059){ref-type="fig"}.

Structure and function of the system
------------------------------------

Dynamic web pages allow the physician to run the software and then store, retrieve, compute, and show patient's data. In this way, all data and software are located on the server alone and no special client software is needed on the physicians' personal computer. The only requirement for the user is to know the server web address and to own a registered account. This web architecture permits direct access from any location, allowing the server administrator to monitor incoming connections. A further operative advantage is that updates and changes made to the software on the web server are immediately available to all other computers simultaneously.

Patient record
--------------

Events, diseases, parameters, qualitative data, and even diagnosis, indications, and messages are all coded in such a way as to better computerize data mining and parameter extraction. [Table 1](#t1-tcrm-7-059){ref-type="table"} shows the design scheme for patient's record. The data model is tree- structured, creating a user-friendly interface to record selectively and show patient data by means of nested multichoice frames ([Figure 2](#f2-tcrm-7-059){ref-type="fig"}). The data detail navigation can be stopped at any level and the detail frames and choice types are dynamically shown on the basis of the values of current data. This data-oriented model facilitates modification and upgrading of data without making changes to the software. From such data classification, an automatic final medical report may be created and, strictly for clinical purposes, be integrated with notes by the physician. The report composition ([Figure 3](#f3-tcrm-7-059){ref-type="fig"}) is obtained by referring to a clinical model of the patient record (main events, socio-economical factors, family and personal history, psychosocial events, physical activity, alcohol and dietary habits, atherosclerotic factors, kidney function, remote and actual pathologies, surgery interventions and hospitalization, symptoms and clinical signs, clinical-basal parameters, blood tests, ongoing therapies, referral for diagnostic tests). Other medical speciality areas can then be activated by simply integrating and updating the database with new patient data. A sharp separation exists between the data, structured together with the model, and the program, which uses tree-structured frames as a general user interface and which supply the engine for accessing and processing the data according to the model. This method enables the data, and even the model, to be upgraded easily and immediately, because the program need not be modified and the system can be implemented simply in another specialist area, changing only the data and the related model.

Program
-------

The software allows the physician to select between first consultation and consecutive consultation, which avoids rewriting static patient data. Throughout follow-up, the physician can evaluate the evolution of the patient's health status through charts and trends, estimate changes in risk factors over time, evaluate success in risk reduction, and personalize policy against risk scores. [Figure 4](#f4-tcrm-7-059){ref-type="fig"} shows the program navigation strategy following the user identification. At the first consultation, information on vital statistics, historical data, ethnic origin, education, past pathologies, as well as static data and social--economic and psychosocial factors, are collected by the physician or trained nurse; thereafter, the information will be automatically presented by the software at each consecutive consultation, with the possibility of if being updated. On the other hand, dynamic data, such as clinical parameters, actual diseases, therapy, and life-style, must be recorded at each consultation. Data and outcome estimates can then be printed. [Figure 5](#f5-tcrm-7-059){ref-type="fig"} summarizes the program data flow with the screenshots showing the phases of the navigation.

Main events related to CV risk, such as heart attack, stroke, and other significant events can be recorded with timing of event. Subsequently the software promptly informs the physician of the stored event when he or she accesses the patient data.

Nested multiple choice frames aid the physician in conducting the physical examination of the patient according to standard clinical good practice criteria to establish a standard model of clinical data description.

Pilot study
-----------

We set up a pilot study to define the feasibility and the clinical utility of the web-based program, and identify any glitches. To do this, we selected five doctors working in different cities of the Tuscany region who used computers in their daily practice.

Before starting the pilot study we arbitrarily defined the outcome as cut-offs that could be used to define the success or not of the pilot study, ie: -- cut-off for recruitment -- at least 200 patients in 6 months and at least 40 patients for each recruiter-- cut-off for feasibility -- glitches \<10% during consultation average consultation time \<20 minutes in \>80% of consultations-- cut-off for clinical powerful -- evidence for at least 2 concomitant emerging CV risk factors in \>30% of subjects.

Results
=======

The medical layout and main fields are shown in [Figure 6](#f6-tcrm-7-059){ref-type="fig"}. By selecting the button and list icons further details can be obtained in subsequent frames.

Technical system
----------------

The software enables the physician to identify the patient's CV state through several computing and referring instruments, as listed below: -- Computed CV risk factor: Framingham, Procam, Progetto Cuore indexes[@b19-tcrm-7-059],[@b20-tcrm-7-059],[@b27-tcrm-7-059] are promptly computable to supply absolute, relative, and baseline 10-year CV risk of CV events. The software allows changes to one or all of the patient's modifiable parameter values (eg, cholesterol, pressure, smoking) to predict the new (ie, relative) CV risk factor ([Figure 7](#f7-tcrm-7-059){ref-type="fig"}).-- The program considers all the algorithms: a) the global risk (absolute) related to the different parameters utilized for each algorithm; b) the basic risk (baseline) deduced from static (ie, sex and age) parameters from the patient and by including all the modifiable parameters as normal; c) the hypothetic, expected risk (relative) by starting from the parameters measured for the patient and by assuming the normalization of one or more parameters.-- Patient objectives: [Figure 3](#f3-tcrm-7-059){ref-type="fig"} shows a typical example of data collected for a 63-year-old, smoker, normotensive, hyperlipidemic female, with no physical activity or Mediterranean diet. The quantitative values of prescriptions, computed for CV risk target, can be adjusted by the physician in agreement with the patient in order to establish together a personalized therapeutic path that the patient could indeed follow in his or her daily life. The effect of patient compliance must be evaluated by the physician at the next consultation and, if necessary, discussed again.-- Multiparametric/agreed and predicted graph/trends. Temporal trends of different kinds of the patient's multiple data arising from actual and previous consultations can be shown on a table or on a plot underlying the relationships among different parameters. Moreover, each single parameter is plotted in a graph as real values recorded at consultations together with the target value (obtained from guidelines and the value the physician agreed with the patient during the objectives definition phase (microgoals). This kind of plot allows the physician (and the patient) to evaluate the effectiveness of a personalized therapeutic path ([Figure 8](#f8-tcrm-7-059){ref-type="fig"}).-- Critical values: To better characterize the patient's clinical status, the software is able to present evidence for all clinical parameters that can be considered critical according to international recommendations.[@b14-tcrm-7-059],[@b18-tcrm-7-059],[@b22-tcrm-7-059] The software takes into account the comorbidity effects (eg, diabetes, hypertension, hyperlipidemia) that change the target values derived from single pathology guidelines.[@b14-tcrm-7-059] This suggestion aims to reduce possible omissions or underestimations of the patient data by the physician, leaving them free to make their own evaluation.-- Medical report: At the end of the consultation, the structured data are automatically summarized in natural text in a report like the typical medical report, which can be stored or printed for further consultation as a unique document describing the consultation. The physician might change it or update it in free text, which is not computable for epidemiological analysis.

Pilot study validation
----------------------

The main data derived from the pilot study are reported in [Tables 3](#t3-tcrm-7-059){ref-type="table"}--[7](#t7-tcrm-7-059){ref-type="table"}. [Table 2](#t2-tcrm-7-059){ref-type="table"} shows the main demographic data for the sample utilized in the pilot study. [Figure 9](#f9-tcrm-7-059){ref-type="fig"} depicts the geographical distribution of the doctors involved in pilot study. A total of 294 patients was recruited in 6 months and only 1 out of the 5 doctors did not reach the 40 recruitments cut-off ([Table 3](#t3-tcrm-7-059){ref-type="table"}).

1.  -- Feasibility: Global time to collect data at first consultation was 13 ± 11 minutes which declined to 8 ± 7 minutes at the subsequent consultation. Of first consultations, 16% were more the 20 minutes ([Table 4](#t4-tcrm-7-059){ref-type="table"}).

2.  -- Glitches: Technical glitches, such as trouble entering server, were observed in only 2% of cases. Very occasionally doctors were unable to find a suitable choice among program proposals (ie, heavy drinking only once a week).

3.  -- Clinical validation: [Table 5](#t5-tcrm-7-059){ref-type="table"} reports the percentage of positive primary and additional risk factors in the studied population. [Table 6](#t6-tcrm-7-059){ref-type="table"} reports the difference in CV risk estimate by different algorithms according to the severity of computed risk. In 48.2% of cases ([Table 7](#t7-tcrm-7-059){ref-type="table"}) the program revealed 2 or more parameters out of the main guideline indications and gives specific clinical suggestions to return parameters to target values. As shown in [Table 7](#t7-tcrm-7-059){ref-type="table"}, the CV risk factor numbers of the studied population are independent from sex and age: more than 80% had at least 1 CV risk factor and almost half had 2 CV risk factors. Notably, additional CV risk factors (eg, obesity and mental stress) were highly represented in the population ([Table 5](#t5-tcrm-7-059){ref-type="table"}). Also, more than 44% of cases/patients showed at least 2 or more additional CV risk factors.

Discussion
==========

The management of primary and secondary CV prevention is increasingly complex due to i) its intrinsic multidisciplinary nature and ii) the rapid growth of pathophysiological knowledge in the field.[@b6-tcrm-7-059],[@b12-tcrm-7-059],[@b14-tcrm-7-059],[@b15-tcrm-7-059],[@b23-tcrm-7-059]--[@b25-tcrm-7-059] A well-designed computer based program might thus represent a useful tool to assist physicians during their daily clinical practice.[@b26-tcrm-7-059] The main advantages over the currently available computerized systems to assess CV risk[@b19-tcrm-7-059],[@b20-tcrm-7-059],[@b26-tcrm-7-059],[@b27-tcrm-7-059] are the result of the web-based architecture. First, no software needs to be installed on the doctor's computer and the patient data between client and server does not need upgrading because all data and software reside on the server; only a low download speed internet link is required, since the amount of data transferred is very low. Second, all patient data on the server are updated at all times, and are available worldwide at any time; changes in the program and upgrade of guidelines are immediately usable.

In current clinical practice doctors separate the CV risk evaluation from the routine consultation, even if they use an electronic patient record program; the purpose of the proposed program is to combine these two phases to avoid data replication.

A real problem arises when doctors already use their own electronic patient record programs. A specific middleware should be developed to integrate both databases and even a data entry interface so that doctors do not input the same data twice.

The major advantages of the computer-based approach described here are: -- Simple and usable data acquisition that is as comprehensive as possible in terms of both well-known and less-known, but emerging, CV risk factors including psychosocial and behavioral factors. In particular, the new computer program is intended to evaluate a large number of parameters instead of the few used to define algorithms of the principal formulae (eg, Framingham, Procam, Progetto Cuore)[@b19-tcrm-7-059],[@b20-tcrm-7-059],[@b27-tcrm-7-059] to calculate absolute and relative CV risk. The proposed web-based CV risk assessment program, compared with similar existing CV risk assessment tools, also enables additional CV risk factors (eg, lifestyle, psychological, stress) and greater details on smoking habits to be collected in a structured manner.[@b19-tcrm-7-059],[@b20-tcrm-7-059],[@b26-tcrm-7-059],[@b27-tcrm-7-059] The use of a computer program enables the doctor to automatically retrieve from the database data on the patient's previous consultation, inputting only new values, such as blood pressure values, weight, and therefore reducing check-up time. Moreover, adoption of hardware/software instruments as data entry by means of web forms or optical scanning of typewritten sheet might further simplify and speed up program use.-- The program clearly displays and quantifies the comparison between the CV risk indexes of risk measured for the patient and those measured for an age- and sex-matched reference population with indexes accepted as normal. Notably, the program can be used during a consultation to allow the patient to immediately understand the health benefits predicted with changes in lifestyle (eg, stopping smoking or drug abuse, or antihypertensive and/or lowering lipid treatment). Through the current configuration the program automatically shows both physician and patient the entity of risk reduction by a specific change in one or more of the abnormal risk factors.-- The program is highly flexible in its potential use and application. One part can be used for statistical and epidemiological purposes (ie, definition of a new chart of CV risk for the population under surveillance) and another can be used to explore and collect additional clinical data to improve patient adherence to therapeutic strategy.[@b28-tcrm-7-059] It is noteworthy that slightly reducing the weight of risk factors can be more beneficial than a greatly reducing a single risk factor.[@b14-tcrm-7-059] A target level of risk reduction might be achieved by several different routes, and the patient could participate in deciding which route to follow. The program may also help the doctor to improve personal feedback and monitoring of data of interest during treatment by producing graphical trends or tabulations of single or multiple parameters over time.-- The program has a substantial component of automated checking systems that reduce the risk of diagnostic omissions and identifies critical laboratory values according to international guidelines.[@b22-tcrm-7-059] Even more important is the possibility during a consultation to automatically compare the chosen therapeutic program with the more reliable guidelines or international recommendation in the field. In an era of evidence-based medicine this represents a fundamental tool to convince both doctor and patient of the importance of the program.-- Finally three major comments can be made about the pilot clinical study: The new tool is a feasible and practical way of computing CV risk in clinical practice within an acceptable time frame ([Table 4](#t4-tcrm-7-059){ref-type="table"});The large variability observed when adopting different algorithms to compute CV risk ([Table 6](#t6-tcrm-7-059){ref-type="table"}) in the same subject suggests the need to implement a new, specific algorithm for each population under study;The high percentage of more than one additional CV risk factor (eg, mental stress, obesity, physical activity) in 44% of patients suggests the need for further systematic evaluation of the relative weight of these parameters when computing CV risk.

Conclusion
==========

The system we propose represents a feasible and flexible tool for clinical management of patients and epidemiological research.

Moreover, the acquisition of structured data enables later queries during epidemiological studies. A new algorithm based on primary and emerging CV risk factors could be provided for the specific population under evaluation after collection of a significant amount of patient data by the present web-based system. Because the software is server-based, upgrades are immediately available to all users.

Summary
=======

-   The classical algorithms used for CV risk assessment do not take into account several emerging CV risk factors

-   Very often, CV risk indexes are computed from different populations without considering the specific features of the actual population

-   Usually, CV risk estimates and electronic medical records are separate

-   The access from common computers is easy despite operating system and application software

-   A centralized medical database is available that enables the patient to be followed up wherever they are; authorized sharing of patient clinical status between different doctors and specialists

-   Real time update/upgrades of medical guidelines, patient data, and system

-   Standardized medical support for patient medical consultation

-   Personalized therapy and lifestyle changes with patient agreement
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![Example of consequent frames in a multichoice answer used in the patient record.](tcrm-7-059f2){#f2-tcrm-7-059}

![Example of the program's indications for a typical patient.\
**Abbreviations:** BP, blood pressure; BMI, body mass index; CV, cardiovascular; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TGL, triglycerides.](tcrm-7-059f3){#f3-tcrm-7-059}
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![Example of absolute, baseline and predicted CV risk as computed by the program.](tcrm-7-059f7){#f7-tcrm-7-059}

![Example of agreed and predicted graph (red: measured, green: agreed by the doctor, blue: predicted by guidelines).](tcrm-7-059f8){#f8-tcrm-7-059}

![Regional distribution of patients and doctors (general practitioner, GP and specialist, Spec) in the pilot study.](tcrm-7-059f9){#f9-tcrm-7-059}

###### 

Design scheme for patient record

  **Personal data**   **Frame**                                                              **First level details**
  ------------------- ---------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  **Medical data**    ***Socio-economic factors***                                           
                      Study degree                                                           Primary, secondary, bachelor,..
                      Professional activity                                                  Employed, unemployed, retired,..
                      Main job occupation                                                    Manual job, intellectual job, driver, manager,..
                      ***Family history***                                                   
                      Relatives up to 2nd degree                                             CV death/main CV and non-CV diseases and risk factors (diabetes, hyperlipidemia.,..)
                      ***Personal history***                                                 
                      Sleep disorders                                                        (trouble to sleep, early wake up,..)
                      Gynecologic/obstetric diseases                                         (polycystic ovary, pregnancy, diabetes,..)
                      ***Psychosocial factors***                                             
                      Adverse life events                                                    Self-reported personal/family/job/financial events/troubles
                      Psychological factors                                                  Self-reported depression/stress/emotional factors/vitality
                      ***Lifestyle***                                                        
                      Physical activity                                                      Amount/frequency/type (ie, hours per week,..)
                      Diet                                                                   Alcohol type (wine, beer, spirit), and amount per day
                                                                                             Mediterranean diet adherence by a validated score
                      ***Individual CV risk factors***                                       
                      Primary factors (diabetes, obesity, hyperlipidemia, hypertension,..)   Diabetes duration, insulin dependent or noninsulin-dependent diabetes,..
                      Smoke                                                                  Type, amount, length (ie, pack-years),..
                      ***Preclinic atherosclerosis***                                        Left ventricular hypertrophy calcium score, intima media thickness...
                      ***Previous diseases***                                                Main remote pathologies: gastrointestinal, neurologic, pulmonary, uro-genital, vascular diseases,...
                      ***Hospitalization***                                                  Number and type (CV or non-CV) of admission during last year
                      ***Surgical/CV procedures***                                           Main procedures: District (ie, aorta, coronary, renal), date of intervention...
                      ***Actual diseases***                                                  
                      CV pathologies                                                         Type (ie, angina, ischemic card. dis., stoke), year, detail
                      Non CV pathologies                                                     Type (ie, renal, endocrine, collagen diseases..)
                      ***Clinical-chemical parameters***                                     
                      Basic vital signs                                                      BP, HR, BMI, waist, hip circumference,..
                      Bio-humoral tests                                                      Date, type and value
                      ***CV consultation***                                                  
                      Main symptoms and clinical signs                                       Type and detail (ie, chest pain, dyspnea, vascular murmurs, declive edema, NYHA class.,...
                      ***Ongoing therapies***                                                Drug: international nonproprietary name, trade name, dosage

**Abbreviations:** BP, blood pressure; BMI, body mass index ; CV, cardiovascular; HR, heart rate; NYHA, New York Heart Association.

###### 

Demographic information about the sample used for the pilot study

                       **GP (n = 2)**   **Specialist (n = 3)**   **Total**
  -------------------- ---------------- ------------------------ -----------
  Recruited patients   163              131                      294
  Male/female          96/67            60/71                    294
  Age                  59 ± 10          62 ± 15                  60 ± 12
  BMI                  27.1 ± 4         25.3 ± 4                 26.2 ± 4

**Abbreviation:** GP, general practitioner.

###### 

Consultation statistics for the pilot study

  **Doctors**   **Patient number**            
  ------------- -------------------- -------- ---------
  Doct. 1       63                   3        66
  Doct. 2       21                   0        21
  Doct. 3       43                   0        43
  Doct. 4       67                   12       79
  Doct. 5       100                  6        106
  Total         **294**              **20**   **315**

###### 

Global time to collect data at first and subsequent consultation

  **Consultation time (minutes)**   **First**     **Subsequent**
  --------------------------------- ------------- ----------------
  \<5                               12%           36%
  From 5 to 10                      37%           29%
  From 10 to 15                     28%           21%
  From 15 to 20                     9%            7%
  From 20 to 25                     4%            0%
  From 25 to 30                     5%            7%
  \>30                              7%            0%
  Mean (±SD)                        **13 ± 11**   **8 ± 7**

###### 

Percentage of primary and additional cardiovascular (CV) risk factors (RF) found in the pilot study

  **Primary CV RF**       **% male**   **% female**
  ----------------------- ------------ --------------
  Hypercholesterolemia    62           63
  Hypertriglyceridemia    42           26
  Hypertension            25           14
  Diabetes                9            6
  Smoking habit           14           10
  **Additional RF**                    
  Overweight              19           18
  Obesity                 48           26
  No Mediterranean diet   68           86
  No physical activity    55           66
  Mental stress           38           53

###### 

Normalized difference in cardiovascular (CV) risk factor computation by different algorithms according to the severity of computed risk

  **CV risk %**   **Framingham**   **Procam**   **Prog. Cuore**
  --------------- ---------------- ------------ -----------------
  \<5%            26%              55%          54%
  5%--10%         25%              12%          22%
  10%--15%        19%              6%           15%
  15%--20%        9%               5%           4%
  20%--25%        6%               4%           3%
  25%--30%        3%               5%           2%
  \>30%           11%              13%          2%

###### 

Percentage of patients with principal cardiovascular (CV) risk factors (ie, blood pressure, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, glycemia, smoke) from the main guideline indications on the basis of the three adopted algorithms

  **Number**   **Male**   **Female**                    
  ------------ ---------- ------------ ---- ----- ----- ----
  0            19%                     57   17%         60
  1            35%        81%          64   32%   83%   61
  2            29%        46%          60   23%   51%   58
  3            13%        17%          59   16%   27%   63
  4            3%         4%           75   10%   11%   58
  5            1%         1%           63   1%    1%    67
  6            0%         0%                0%    0%    
  7            0%         0%                0%    0%    

**Abbreviation:** cum., cumulative.
